174 filings
8-K
RNXT
RenovoRx, Inc.
25 Sep 24
Company expands relationship with manufacturing partner Medical Murray, and continues active exploration of standalone opportunities for RenovoCath
4:10pm
8-K
RNXT
RenovoRx, Inc.
16 Aug 24
Changes in Registrant's Certifying Accountant
4:05pm
10-Q
2024 Q2
RNXT
RenovoRx, Inc.
Quarterly report
13 Aug 24
5:03pm
8-K
RNXT
RenovoRx, Inc.
7 Jun 24
Departure of Directors or Certain Officers
4:41pm
EFFECT
RNXT
RenovoRx, Inc.
13 May 24
Notice of effectiveness
12:15am
EFFECT
RNXT
RenovoRx, Inc.
13 May 24
Notice of effectiveness
12:15am
10-Q
2024 Q1
RNXT
RenovoRx, Inc.
Quarterly report
10 May 24
5:21pm
424B3
RNXT
RenovoRx, Inc.
10 May 24
Prospectus supplement
4:50pm
424B3
RNXT
RenovoRx, Inc.
10 May 24
Prospectus supplement
4:47pm
8-K
RNXT
RenovoRx, Inc.
3 May 24
Changes in Registrant's Certifying Accountant
5:00pm
DEF 14A
RNXT
RenovoRx, Inc.
Definitive proxy
30 Apr 24
4:30pm
S-3
RNXT
RenovoRx, Inc.
Shelf registration
26 Apr 24
5:01pm
D
RNXT
RenovoRx, Inc.
22 Apr 24
$15.00 mm in equity / options / securities to be acquired, sold $11.14 mm, 172 investors
11:26am
S-3
RNXT
RenovoRx, Inc.
Shelf registration
19 Apr 24
5:01pm
8-K
RNXT
RenovoRx, Inc.
18 Apr 24
Other Events
4:15pm
8-K
RNXT
RenovoRx, Inc.
16 Apr 24
Other Events
8:00am
8-K
RNXT
RenovoRx, Inc.
15 Apr 24
Unregistered Sales of Equity Securities
9:00am
S-8
RNXT
RenovoRx, Inc.
12 Apr 24
Registration of securities for employees
5:14pm
8-K
RNXT
RenovoRx, Inc.
9 Apr 24
RenovoRx Announces $11.1 Million At Market Private Placement
4:15pm
10-K
2023 FY
RNXT
RenovoRx, Inc.
Annual report
1 Apr 24
4:05pm